| Literature DB >> 35573276 |
Elizabeth Huliganga1,2, Francesco Marchetti2, Jason M O'Brien3, Vinita Chauhan4, Carole L Yauk1,2.
Abstract
Adverse outcome pathways (AOPs) synthesize toxicological information to convey and weigh evidence in an accessible format. AOPs are constructed in modules that include key events (KEs) and key event relationships (KERs). This modular structure facilitates AOP expansion and network development. AOP development requires finding relevant information to evaluate the weight of evidence supporting each KER. To do this, the use of transparent/reproducible search methods, such as systematic review (SR), have been proposed. Applying SR to AOP development in a data-rich area is difficult as SR requires screening each article returned from a search. Here we describe a case study to integrate a single new KE into an existing AOP. We explored the use of SR concepts and software to conduct a transparent and documented literature search to identify empirical data supporting the incorporation of a new KE, increase in cellular reactive oxygen species (ROS), upstream of an existing AOP: "Oxidative DNA Damage Leading to Chromosomal Aberrations and Mutations". Connecting this KE to the AOP is supported by the development of five new KERs, the most important being the first adjacent KER (increase in ROS leading to oxidative DNA damage). We initially searched for evidence of all five KERs and screened 100 papers to develop a preliminary evidence map. After removing papers not containing relevant data based on our Population, Exposure, Comparator and Outcome statement, 39 articles supported one or more KERs; these primarily addressed temporal or dose concordance of the non-adjacent KERs with limited evidence supporting the first adjacent KER. We thus conducted a second focused set of searches using search terms for specific methodologies to measure these first two KEs. After screening, 12 articles were identified that contained quantitative evidence supporting the first adjacent KER. Given that integrating a new KE into an existing AOP requires the development of multiple KERs, this approach of building a preliminary evidence map, focusing evidence gathering on the first adjacent KER, and applying reproducible search strategies using specific methodologies for the first adjacent KER, enabled us to prioritize studies to support expansion of this data-rich AOP.Entities:
Keywords: DNA damage; adverse outcome pathways; genotoxicity; reactive oxygen species; toxicology
Year: 2022 PMID: 35573276 PMCID: PMC9097222 DOI: 10.3389/ftox.2022.827328
Source DB: PubMed Journal: Front Toxicol ISSN: 2673-3080
FIGURE 1AOPs that converge on KEs associated with genotoxicity were extracted from the AOP-wiki and adapted from those proposed by Sasaki et al. (2020). These AOPs were chosen to demonstrate the growing network of shared KEs and KERs that form a network leading to chromosome damage and mutations. A network of KEs leading to aneuploidy is being developed separately. MIEs: molecular initiating events.
FIGURE 2Flow diagram of the adverse outcome pathway ‘Oxidative damage leading to mutations and chromosomal aberrations’ (Cho et al., 2022).
Search strings for broad and focused literature searches.
| Search Number | Search String | # of results retrieved (12 February 2021) |
|---|---|---|
| 1 (broad search) | (Reactive Oxygen Species) AND (DNA Damage) | 236,505 |
| Focused searches | # of results retrieved (28 October 2021) | |
| 2 | (FPG-modified comet) AND (Electron paramagnetic resonance spectroscopy) | 2 |
| 3 | (FPG-modified comet) AND (Electrochemical detection of ROS) | 16 |
| 4 | (FPG-modified comet) AND (HyPer) | 4 |
| 5 | (FPG-modified comet) AND (Hydroethidine) | 0 |
| 6 | (FPG-modified comet) AND (Mito-SOX) | 1 |
| 7 | (FPG-modified comet) AND (Mito-HE) | 8 |
| 8 | (FPG-modified comet) AND (Electrode detection of ROS) | 9 |
| 9 | (FPG-modified comet) AND (Boronate probes) | 1 |
| 10 | (FPG-modified comet) AND (CellROX) | 0 |
| 11 | (ELISA) AND (8-oxodG)AND (Electron paramagnetic resonance spectroscopy) | 2 |
| 12 | (ELISA) AND (8-oxodG) AND (Electrochemical detection of ROS) | 73 |
| 13 | (ELISA) AND (8-oxodG) AND (HyPer) | 18 |
| 14 | (ELISA) AND (8-oxodG) AND (Hydroethidine) | 3 |
| 15 | (ELISA) AND (8-oxodG) AND (Mito-SOX) | 0 |
| 16 | (ELISA) AND (8-oxodG) AND (Mito-HE) | 11 |
| 17 | (ELISA) AND (8-oxodG) AND (Electrode detection of ROS) | 14 |
| 18 | (ELISA) AND (8-oxodG) AND (Boronate probes) | 1 |
| 19 | (ELISA) AND (8-oxodG) AND (CellROX) | 0 |
| 20 | (LC-MS) AND (8-oxodG)AND (Electron paramagnetic resonance spectroscopy) | 2 |
| 21 | (LC-MS) AND (8-oxodG) AND (Electrochemical detection of ROS) | 57 |
| 22 | (LC-MS) AND (8-oxodG) AND (HyPer) | 6 |
| 23 | (LC-MS) AND (8-oxodG) AND (Hydroethidine) | 1 |
| 24 | (LC-MS) AND (8-oxodG) AND (Mito-SOX) | 0 |
| 25 | (LC-MS) AND (8-oxodG) AND (Mito-HE) | 2 |
| 26 | (LC-MS) AND (8-oxodG) AND (Electrode detection of ROS) | 10 |
| 27 | (LC-MS) AND (8-oxodG) AND (Boronate probes) | 2 |
| 28 | (LC-MS) AND (8-oxodG) AND (CellROX) | 0 |
| 29 | (HPLC-EC) AND (8-oxodG)AND (Electron paramagnetic resonance spectroscopy) | 2 |
| 30 | (HPLC-EC) AND (8-oxodG) AND (Electrochemical detection of ROS) | 45 |
| 31 | (HPLC-EC) AND (8-oxodG) AND (HyPer) | 3 |
| 32 | (HPLC-EC) AND (8-oxodG) AND (Hydroethidine) | 0 |
| 33 | (HPLC-EC) AND (8-oxodG) AND (Mito-SOX) | 0 |
| 34 | (HPLC-EC) AND (8-oxodG) AND (Mito-HE) | 3 |
| 35 | (HPLC-EC) AND (8-oxodG) AND (Electrode detection of ROS) | 10 |
| 36 | (HPLC-EC) AND (8-oxodG) AND (Boronate probes) | 0 |
| 37 | (HPLC-EC) AND (8-oxodG) AND (CellROX) | 0 |
Population, Exposure, Endpoint statement, for the inclusion/exclusion of full text screening.
| Modified PECO element | Evidence |
|---|---|
| Populations | Animal (all levels), human, |
| Exposures | Reactive Oxygen Species (ROS), Reactive Nitrogen Species (RNS), Chemicals or Stressors causing an increased production of ROS/RNS (directly or indirectly) |
| Endpoints | All KEs in AOP: Cellular Reactive Oxygen Species (ROS), Oxidative DNA damage, Inadequate repair, Mutations, DNA strand breaks and Chromosomal aberrations |
Quantitative and reliable methods measuring cellular ROS or oxidative DNA damage used in search terms for focused search.
| Methods measuring cellular ROS | Methods measuring oxidative DNA damage |
|---|---|
| Electron paramagnetic resonance spectroscopy | FPG-modified comet |
| Electrochemical detection of ROS | ELISA AND 8-oxodG |
| HyPer | LC-MS AND 8-oxodG |
| Hydroethidine | HPLC-EC AND 8-oxodG |
| Mito-SOX | — |
| Mito-HE | — |
| Electrode detection of ROS | — |
| Boronate probes | — |
| CellROX | — |
8-oxodG was added to indicated search terms because these methods are not specific to the detection of oxidative DNA damage.
FIGURE 3Flow diagram of the adverse outcome pathway “Oxidative damage leading to mutations and chromosomal aberrations” (Cho et al., 2022) with the inclusion of an upstream KE “increase in cellular ROS”, which represents the eventual consensus ROS KE, occurring after the multiple MIEs by which ROS are produced after toxicant exposure, and the resulting new KERs.
FIGURE 4Flow chart showing the number of articles included and excluded at each step of the broad literature review.
Evidence map describing the number of articles identified through the screening that measured each key event (KE) in the “Oxidative DNA damage leading to chromosomal aberrations and mutations” pathway as well as increases in ROS.
| KE1: Oxidative DNA damage | KE2: Inadequate repair | KE3: DNA strand breaks | AO1: Mutations | AO2: Chromosomal aberrations | |
|---|---|---|---|---|---|
| KE1: Oxidative DNA damage | 5 | 1 | 4 | 1 | 0 |
| KE2: Inadequate repair | — | 3 | 1 | 1 | 1 |
| KE3: DNA strand breaks | — | — | 35 | 1 | 0 |
| AO1: Mutations | — | — | — | 2 | 1 |
| AO2: Chromosomal aberrations | — | — | — | — | 1 |
Evidence map describing the number of articles retrieved in the screening that addresses each type of empirical evidence required to evaluate the weight of evidence of a KER.
| Temporal concordance | Dose/concentration concordance | Incidence concordance | Conflicting | |
|---|---|---|---|---|
| Temporal concordance | 32 | 16 | 0 | 0 |
| Dose/concentration concordance | — | 21 | 0 | 0 |
| Incidence concordance | — | — | 0 | 0 |
| Conflicting | — | — | — | 1 |
FIGURE 5Flow chart showing the number of articles included and excluded at each step of the specific literature search.